By Will Dunham WASHINGTON (Reuters) - Taking a popular class of pain relievers that includes aspirin and ibuprofen lowers the levels of a protein in a man's blood that doctors use to screen for prostate cancer, U.S. researchers said on Monday. But the researchers said it is unclear whether this means these men have a lower risk for developing prostate cancer or these medications may make it harder to detect...
[read full story]
Taking painkillers such as Aspirin and ibuprofen appears to lower PSA levels in a man's blood that are used to screen for prostate cancer. It's possible the effect could interfere with test results, say researchers, who...
TORONTO, Sept. 9 /CNW/ - The Prostate Cancer Research Foundation of Canada is putting a call out to women to help get more men to the doctor this year for their annual physical. Survey results released today show that...
Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer. "We showed that men who regularly...
From correspondents in Washington, United States, 01:02 PM IST Regular use of nonsteroid anti-inflammatory drugs (NSAIDs) like aspirin and ibuprofen is likely to hamper the detection of prostate cancer. Researchers suspect...